查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1869660

神經刺激設備市場規模、佔有率和趨勢分析報告：按產品、應用、最終用途、地區和細分市場預測（2025-2033 年）

Neurostimulation Devices Market Size, Share & Trends Analysis Report By Product, By Applications, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

神經刺激設備市場摘要

2024年全球神經刺激設備市場規模估計為58億美元，預計2033年將達到139.3億美元。

預計從 2025 年到 2033 年，該市場將以 10.29% 的複合年成長率成長。市場成長歸因於神經系統疾病盛行率的上升、對微創療法的偏好增加以及對長期疼痛管理解決方案的需求增加。

閉合迴路刺激、MRI相容設備以及電池續航力的提升等技術進步，提高了治療的精準度和患者療效，促進了神經刺激療法在臨床上的廣泛應用。此外，神經刺激療法在慢性疼痛、癲癇、帕金森氏症、憂鬱症、脊髓損傷等疾病中的適應症不斷擴大，加之許多地區訂定了支持性的醫療政策，進一步推動了市場成長。

政府投入的增加是神經刺激設備市場發展的關鍵驅動力，加速了先進神經刺激技術的研發，並擴大了其治療應用範圍。政府對研究計畫、臨床試驗和創新舉措的資助，有助於加深對神經系統疾病的了解，並支持神經刺激治療方法的突破。這種資金支持促進了研究人員、臨床醫生和醫療設備開發商之間的合作，有助於將安全性更高、更精準、更療效的新一代系統推向市場。此外，旨在改善醫療服務可近性和降低神經系統疾病治療成本的政府舉措，也間接促進了神經刺激療法的應用，使其惠及更廣泛的患者群體，從而推動了整體市場成長。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章神經刺激設備市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 神經刺激設備市場分析工具
    • 波特五力分析
    • PESTEL 分析

第4章神經刺激設備市場：依產品分類的估算與趨勢分析

  • 細分儀表板
  • 全球神經刺激設備市場：按產品分類的變化分析（2024 年和 2033 年）
  • 全球神經刺激設備市場規模及產品趨勢分析（2021-2033年）
  • 脊髓刺激設備
  • 深層腦部刺激器
  • 薦骨神經刺激器
  • 迷走神經刺激設備
  • 胃電刺激
  • 其他

第5章神經刺激設備市場：按應用分類的估算與趨勢分析

  • 細分儀表板
  • 全球神經刺激設備市場：按應用領域分類的變化分析（2024 年和 2033 年）
  • 全球神經刺激設備市場規模及應用趨勢分析（2021-2033年）
  • 帕金森氏症
  • 慢性疼痛
  • 偏頭痛
  • 癲癇
  • 震顫
  • 憂鬱症
  • 尿失禁/糞便失禁
  • 其他

第6章神經刺激設備市場：依最終用途分類的估算與趨勢分析

  • 細分儀表板
  • 全球神經刺激設備市場：按最終用途分類的變化分析（2024 年和 2033 年）
  • 全球神經刺激設備市場規模及趨勢分析（依最終用途分類，2021-2033年）
  • 醫院和門診手術中心（ASC）
  • 診所/物理治療中心
  • 其他

第7章神經刺激設備市場：區域估算與趨勢分析

  • 區域儀錶板
  • 市場規模及趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 丹麥
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 2023年企業市佔率分析
  • 公司熱力圖分析
  • 策略規劃
    • 擴張
    • 併購
    • 夥伴關係與合作
    • 新產品發布
    • 研究與開發
    • 公司簡介
    • Abbott (St. Jude Medical)
    • Medtronic
    • Boston Scientific Corporation
    • Aleva Neurotherapeutics
    • Nexstim
    • LivaNova PLC
    • Neuropace Inc.
    • Nevro Corporation
    • electroCore, Inc.
    • Axonics, Inc.
    • Nalu Medical
    • Mainstay Medical
    • Saluda Medical Pty Ltd
    • Biotronik
    • MicroTransponder Inc.
    • tVNS Technologies GmbH
    • Laborie
Product Code: 978-1-68038-066-8

Neurostimulation Devices Market Summary

The global neurostimulation devices market size was estimated at USD 5.80 billion in 2024 and is projected to reach USD 13.93 billion by 2033, growing at a CAGR of 10.29% from 2025 to 2033. The growth of the market is attributed due to the rising prevalence of neurological disorders, growing preference for minimally invasive therapies, and increasing demand for long-term pain management solutions.

Technological advancements such as closed-loop stimulation, MRI-compatible devices, and improved battery life enhance treatment precision and patient outcomes, driving wider clinical acceptance. In addition, expanding applications of neurostimulation in conditions such as chronic pain, epilepsy, Parkinson's disease, depression, and spinal cord injuries, along with supportive reimbursement policies in many regions, are further accelerating market growth.

Growing government funding for neuroscience research is a key driver of the neurostimulation devices market, as it accelerates the development of advanced neurostimulation technologies and expands therapeutic applications. By allocating capital to research programs, clinical trials, and innovation initiatives, governments enable a deeper understanding of neurological disorders and support breakthroughs in treatment approaches using neurostimulation. This financial backing fosters collaboration among researchers, clinicians, and medical device developers and encourages the commercialization of next-generation systems with improved safety, precision, and patient outcomes. Furthermore, government initiatives aimed at enhancing healthcare accessibility and reducing the cost burden of neurological care indirectly promote the adoption of neurostimulation therapies, expanding their reach to a broader patient base and fueling overall market growth.

Global Neurostimulation Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global neurostimulation devices market report on the basis of product, application, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Spinal Cord Stimulators
  • Deep Brain Stimulators
  • Sacral Nerve Stimulators
  • Vagus Nerve Stimulators
  • Gastric Electrical Stimulation
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Parkinson's Disease
  • Chronic Pain
  • Migraine
  • Epilepsy
  • Tremor
  • Depression
  • Urinary & Fecal Incontinence
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Ambulatory Surgery Centers (ASC)
  • Clinics & Physiotherapy Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
    • 1.5.1. Data for primary interviews in North America
    • 1.5.2. Data for primary interviews in Europe
    • 1.5.3. Data for primary interviews in Asia Pacific
    • 1.5.4. Data for primary interviews in Latin America
    • 1.5.5. Data for Primary interviews in MEA
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Neurostimulation Devices Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Government funding for research and development
      • 3.2.1.2. Technological advancements in neurostimulation devices
      • 3.2.1.3. Increasing prevalence of neurological disorders
      • 3.2.1.4. Growing reimbursement coverage
      • 3.2.1.5. Expanding applications
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Complex regulatory framework
      • 3.2.2.2. Surgery-associated risk
  • 3.3. Neurostimulation Devices Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal landscape

Chapter 4. Neurostimulation Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Neurostimulation Devices Market: Product Movement Analysis, 2024 & 2033 (USD Million)
  • 4.3. Global Neurostimulation Devices Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Spinal Cord Stimulators
    • 4.4.1. Spinal cord stimulators market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Deep Brain Stimulators
    • 4.5.1. Deep brain stimulators market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6. Sacral Nerve Stimulators
    • 4.6.1. Sacral nerve stimulators market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7. Vagus Nerve Stimulators
    • 4.7.1. Vagus nerve stimulators market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.8. Gastric Electrical Stimulation
    • 4.8.1. Gastric electrical stimulation market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.9. Others
    • 4.9.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Neurostimulation Devices Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Neurostimulation Devices Market: Application Movement Analysis, 2024 & 2033 (USD Million)
  • 5.3. Global Neurostimulation Devices Market Size & Trend Analysis, by Application 2021 to 2033 (USD Million)
  • 5.4. Parkinson's Disease
    • 5.4.1. Parkinson's disease market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Chronic Pain
    • 5.5.1. Chronic pain market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Migraine
    • 5.6.1. Migraine market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.7. Epilepsy
    • 5.7.1. Epilepsy market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.8. Tremor
    • 5.8.1. Tremor market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.9. Depression
    • 5.9.1. Depression market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.10. Urinary & Fecal Incontinence
    • 5.10.1. Urinary & fecal incontinence market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.11. Others
    • 5.11.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Neurostimulation Devices Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Neurostimulation Devices Market: End use Movement Analysis, 2024 & 2033 (USD Million)
  • 6.3. Global Neurostimulation Devices Market Size & Trend Analysis, by End use 2021 to 2033 (USD Million)
  • 6.4. Hospitals & Ambulatory Surgery Centers (ASC)
    • 6.4.1. Hospitals & Ambulatory Surgery Centers (ASC) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5. Clinics & Physiotherapy Centers
    • 6.5.1. Clinics & physiotherapy centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Neurostimulation Devices Market: Regional Estimates & Trend Analysis by Product, Application and End Use

  • 7.1. Regional Dashboard
  • 7.2. Market Size and Trend Analysis, 2021 to 2033
  • 7.3. North America
    • 7.3.1. North America neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Competitive scenario
      • 7.3.2.3. Regulatory framework
      • 7.3.2.4. Reimbursement scenario
      • 7.3.2.5. U.S. neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Competitive scenario
      • 7.3.3.3. Regulatory framework
      • 7.3.3.4. Reimbursement scenario
      • 7.3.3.5. Canada neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key country dynamics
      • 7.3.4.2. Competitive scenario
      • 7.3.4.3. Regulatory framework
      • 7.3.4.4. Reimbursement scenario
      • 7.3.4.5. Mexico neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Competitive scenario
      • 7.4.2.3. Regulatory framework
      • 7.4.2.4. Reimbursement scenario
      • 7.4.2.5. UK neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Competitive scenario
      • 7.4.3.3. Regulatory framework
      • 7.4.3.4. Reimbursement scenario
      • 7.4.3.5. Germany neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Competitive scenario
      • 7.4.4.3. Regulatory framework
      • 7.4.4.4. Reimbursement scenario
      • 7.4.4.5. France neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Competitive scenario
      • 7.4.5.3. Regulatory framework
      • 7.4.5.4. Reimbursement scenario
      • 7.4.5.5. Italy neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Competitive scenario
      • 7.4.6.3. Regulatory framework
      • 7.4.6.4. Reimbursement scenario
      • 7.4.6.5. Spain neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Competitive scenario
      • 7.4.7.3. Regulatory framework
      • 7.4.7.4. Reimbursement scenario
      • 7.4.7.5. Sweden neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Competitive scenario
      • 7.4.8.3. Regulatory framework
      • 7.4.8.4. Reimbursement scenario
      • 7.4.8.5. Denmark neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key country dynamics
      • 7.4.9.2. Competitive scenario
      • 7.4.9.3. Regulatory framework
      • 7.4.9.4. Reimbursement scenario
      • 7.4.9.5. Norway neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. China neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Japan
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory framework
      • 7.5.3.4. Reimbursement scenario
      • 7.5.3.5. Japan neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Competitive scenario
      • 7.5.4.3. Regulatory framework
      • 7.5.4.4. Reimbursement scenario
      • 7.5.4.5. India neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Competitive scenario
      • 7.5.5.3. Regulatory framework
      • 7.5.5.4. Reimbursement scenario
      • 7.5.5.5. South Korea neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Competitive scenario
      • 7.5.6.3. Regulatory framework
      • 7.5.6.4. Reimbursement scenario
      • 7.5.6.5. Australia neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Competitive scenario
      • 7.5.7.3. Regulatory framework
      • 7.5.7.4. Reimbursement scenario
      • 7.5.7.5. Thailand neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. Brazil neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. Argentina neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7. Middle East and Africa
    • 7.7.1. Middle East and Africa neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. South Africa neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. Saudi Arabia neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Competitive scenario
      • 7.7.4.3. Regulatory framework
      • 7.7.4.4. Reimbursement scenario
      • 7.7.4.5. UAE neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Competitive scenario
      • 7.7.5.3. Regulatory framework
      • 7.7.5.4. Reimbursement scenario
      • 7.7.5.5. Kuwait neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Market Share Analysis, 2023
  • 8.4. Company Heat Map Analysis
  • 8.5. Strategy Mapping
    • 8.5.1. Expansion
    • 8.5.2. Mergers & Acquisition
    • 8.5.3. Partnerships & Collaborations
    • 8.5.4. New Product Launches
    • 8.5.5. Research And Development
    • 8.5.6. Company Profiles
    • 8.5.7. Abbott (St. Jude Medical)
      • 8.5.7.1. Company overview
      • 8.5.7.2. Financial performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic initiatives
    • 8.5.8. Medtronic
      • 8.5.8.1. Company overview
      • 8.5.8.2. Financial performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic initiatives
    • 8.5.9. Boston Scientific Corporation
      • 8.5.9.1. Company overview
      • 8.5.9.2. Financial performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic initiatives
    • 8.5.10. Aleva Neurotherapeutics
      • 8.5.10.1. Company overview
      • 8.5.10.2. Financial performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic initiatives
    • 8.5.11. Nexstim
      • 8.5.11.1. Company overview
      • 8.5.11.2. Financial performance
      • 8.5.11.3. Product Benchmarking
      • 8.5.11.4. Strategic initiatives
    • 8.5.12. LivaNova PLC
      • 8.5.12.1. Company overview
      • 8.5.12.2. Financial performance
      • 8.5.12.3. Product Benchmarking
      • 8.5.12.4. Strategic initiatives
    • 8.5.13. Neuropace Inc.
      • 8.5.13.1. Company overview
      • 8.5.13.2. Financial performance
      • 8.5.13.3. Product Benchmarking
      • 8.5.13.4. Strategic initiatives
    • 8.5.14. Nevro Corporation
      • 8.5.14.1. Company overview
      • 8.5.14.2. Financial performance
      • 8.5.14.3. Product Benchmarking
      • 8.5.14.4. Strategic initiatives
    • 8.5.15. electroCore, Inc.
      • 8.5.15.1. Company overview
      • 8.5.15.2. Financial performance
      • 8.5.15.3. Product Benchmarking
      • 8.5.15.4. Strategic initiatives
    • 8.5.16. Axonics, Inc.
      • 8.5.16.1. Company overview
      • 8.5.16.2. Financial performance
      • 8.5.16.3. Product Benchmarking
      • 8.5.16.4. Strategic initiatives
    • 8.5.17. Nalu Medical
      • 8.5.17.1. Company overview
      • 8.5.17.2. Financial performance
      • 8.5.17.3. Product Benchmarking
      • 8.5.17.4. Strategic initiatives
    • 8.5.18. Mainstay Medical
      • 8.5.18.1. Company overview
      • 8.5.18.2. Financial performance
      • 8.5.18.3. Product Benchmarking
      • 8.5.18.4. Strategic initiatives
    • 8.5.19. Saluda Medical Pty Ltd
      • 8.5.19.1. Company overview
      • 8.5.19.2. Financial performance
      • 8.5.19.3. Product Benchmarking
      • 8.5.19.4. Strategic initiatives
    • 8.5.20. Biotronik
      • 8.5.20.1. Company overview
      • 8.5.20.2. Financial performance
      • 8.5.20.3. Product Benchmarking
      • 8.5.20.4. Strategic initiatives
    • 8.5.21. MicroTransponder Inc.
      • 8.5.21.1. Company overview
      • 8.5.21.2. Financial performance
      • 8.5.21.3. Product Benchmarking
      • 8.5.21.4. Strategic initiatives
    • 8.5.22. tVNS Technologies GmbH
      • 8.5.22.1. Company overview
      • 8.5.22.2. Financial performance
      • 8.5.22.3. Product Benchmarking
      • 8.5.22.4. Strategic initiatives
    • 8.5.23. Laborie
      • 8.5.23.1. Company overview
      • 8.5.23.2. Financial performance
      • 8.5.23.3. Product Benchmarking
      • 8.5.23.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America neurostimulation devices market, by region 2021 - 2033 (USD Million)
  • Table 3 North America neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 4 North America neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 5 North America neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 6 U.S. neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 7 U.S. neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 8 U.S. neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 9 Canada neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 10 Canada neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 11 Canada neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 12 Mexico neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 13 Mexico neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 14 Mexico neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 15 Europe neurostimulation devices market, by region 2021 - 2033 (USD Million)
  • Table 16 Europe neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 17 Europe neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 18 Europe neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 19 Germany neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 20 Germany neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 21 Germany neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 22 UK neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 23 UK neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 24 UK neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 25 France neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 26 France neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 27 France neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 28 Italy neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 29 Italy neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 30 Italy neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 31 Spain neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 32 Spain neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 33 Spain neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 34 Denmark neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 35 Denmark neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 36 Denmark neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 37 Sweden neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 38 Sweden neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 39 Sweden neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 40 Norway neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 41 Norway neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 42 Norway neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 43 Asia Pacific neurostimulation devices market, by region 2021 - 2033 (USD Million)
  • Table 44 Asia Pacific neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 47 China neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 48 China neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 49 China neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 50 Japan neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 51 Japan neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 52 Japan neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 53 India neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 54 India neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 55 India neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 56 South Korea neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 57 South Korea neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 58 South Korea neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 59 Australia neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 60 Australia neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 61 Australia neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 62 Thailand neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 63 Thailand neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 64 Thailand neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 65 Latin America neurostimulation devices market, by region 2021 - 2033 (USD Million)
  • Table 66 Latin America neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 67 Latin America neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 68 Latin America neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 69 Brazil neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 70 Brazil neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 71 Brazil neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 72 Argentina neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 73 Argentina neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 74 Argentina neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 75 MEA neurostimulation devices market, by region 2021 - 2033 (USD Million)
  • Table 76 MEA neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 77 MEA neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 78 MEA neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 79 South Africa neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 80 South Africa neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 81 South Africa neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 82 Saudi Arabia neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 83 Saudi Arabia neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 84 Saudi Arabia neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 85 UAE neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 86 UAE neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 87 UAE neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 88 Kuwait neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 89 Kuwait neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 90 Kuwait neurostimulation devices market, by end use 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Neurostimulation devices market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Data analysis models
  • Fig. 5 Market formulation and validation
  • Fig. 6 Data validating & publishing
  • Fig. 7 Market snapshot
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Neurostimulation devices - market size and growth prospects (USD Million)
  • Fig. 11 Neurostimulation devices market: Industry Value Chain Analysis
  • Fig. 12 Neurostimulation devices market: Market Dynamics
  • Fig. 13 Neurostimulation devices market: PORTER's Analysis
  • Fig. 14 Neurostimulation devices market: PESTEL Analysis
  • Fig. 15 Neurostimulation devices market share by product, 2024 & 2033 (USD Million)
  • Fig. 16 Neurostimulation devices market, by product: market share, 2024 & 2033
  • Fig. 17 Spinal cord stimulators market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 18 Deep brain stimulators market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 19 Sacral nerve stimulators market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 20 Vagus nerve stimulators market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 21 Gastric electrical stimulation market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 22 Others market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 23 Neurostimulation devices market share by application, 2024 & 2033 (USD Million)
  • Fig. 24 Neurostimulation devices market, by application: market share, 2024 & 2033
  • Fig. 25 Parkinson's disease market share by application, 2024 & 2033 (USD Million)
  • Fig. 26 Chronic Pain market share by application, 2024 & 2033 (USD Million)
  • Fig. 27 Migraine market share by application, 2024 & 2033 (USD Million)
  • Fig. 28 Epilepsy market share by application, 2024 & 2033 (USD Million)
  • Fig. 29 Tremor market share by application, 2024 & 2033 (USD Million)
  • Fig. 30 Depression market share by application, 2024 & 2033 (USD Million)
  • Fig. 31 Neurostimulation devices market share by application, 2024 & 2033 (USD Million)
  • Fig. 32 Others market share by application, 2024 & 2033 (USD Million)
  • Fig. 33 Neurostimulation devices market share by end use, 2024 & 2033 (USD Million)
  • Fig. 34 Neurostimulation devices market, by end use: market share, 2024 & 2033
  • Fig. 35 Hospitals & Ambulatory Surgery Centers (ASC) market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 36 Clinics & physiotherapy centers market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 37 Others market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 38 Regional marketplace: key takeaways
  • Fig. 39 North America neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 US neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Canada neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Mexico neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Europe neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 UK neurostimulation devices market estimates and forecasts, 2021 - 2033,) (USD Million)
  • Fig. 45 Germany neurostimulation devices market estimates and forecasts (2021 - 2033,) (USD Million)
  • Fig. 46 France neurostimulation devices market estimates and forecasts (2021 - 2033,) (USD Million)
  • Fig. 47 Italy neurostimulation devices market estimates and forecasts (2021 - 2033,) (USD Million)
  • Fig. 48 Spain neurostimulation devices market estimates and forecasts (2021 - 2033,) (USD Million)
  • Fig. 49 Sweden neurostimulation devices market estimates and forecasts (2021 - 2033,) (USD Million)
  • Fig. 50 Denmark neurostimulation devices market estimates and forecasts (2021 - 2033,) (USD Million)
  • Fig. 51 Norway neurostimulation devices market estimates and forecasts (2021 - 2033,) (USD Million)
  • Fig. 52 Asia Pacific neurostimulation devices market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 53 China neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Japan neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 India neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 South Korea neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Australia neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Thailand neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Latin America neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Brazil neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Argentina neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 MEA neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 South Africa neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Saudi Arabia neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 UAE neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Kuwait neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key company categorization
  • Fig. 68 Company market positioning
  • Fig. 69 Key company market share analysis, 2023
  • Fig. 70 Strategic framework